Last reviewed · How we verify
NCT01573897: SAS-FOOT
Impact of Sleep Apnea on Diabetic Foot Wound.
trial in Diabetic Foot in 35 participants. Terminated before completion.
15 November 2016
Quick facts
| Lead sponsor | AGIR à Dom |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 35 |
| Start date | 4 June 2012 |
| Primary completion | 15 November 2016 |
| Estimated completion | 15 November 2016 |
| Sites | 1 location across France |
Conditions studied
- Diabetic Foot — all drugs for Diabetic Foot →
- Sleep Apnea — all drugs for Sleep Apnea →
Sponsor
AGIR à Dom
Who can join
18 and older, any sex, with Diabetic Foot or Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sleep apnea syndrome (SAS) is a common comorbidity of type 1 and type 2 diabetes. A low transcutaneous oxygen tension (PtcO2) measured on the foot is pejorative prognostic factor for the healing of a diabetic foot wound. SAS causes intermittent nocturnal hypoxia and sympathetic overactivity. The investigators hypothesized that SAS could be a factor reducing the PtcO2.Therefore, the main objective of this study is to assess the variation in PtcO2 between the end of the night and midday in patients with -or at risk of- diabetic foot wound according to the presence or not of sleep apnea syndrome.The secondary objective is to address the microvascularisation of diabetic patients having foot wounds according to their status regarding sleep apnea syndrome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01573897
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Foot
Currently open trials in the same condition.
- NCT06487780 — Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers · NA · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
- NCT06760416 — Online Diabetic Foot Support Program- Care Kit · NA · active not recruiting
- NCT06552910 — Analyzing Anesthetic Techniques in Diabetic Foot Amputation · recruiting
- NCT06526936 — The Effect of Foot Care Training Given to Diabetic Hemodialysis Patients on Foot Care Behavior · NA · recruiting
Other AGIR à Dom trials
Trials by the same sponsor.
- NCT04538274 — Trained Patient Involvement to Promote the Resumption of CPAP in Patients Who Have Discontinued Its Use · NA · not yet recruiting
- NCT05653804 — Impact of Tele-visit on Patients Continous Positive Airway Pressure (CPAP) Follow-up by Home Care Provider · NA · active not recruiting
- NCT05621213 — Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation · NA · terminated
- NCT04925739 — Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome · completed
- NCT04716985 — Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Trea · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01573897 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AGIR à Dom
- Last refreshed: 28 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01573897.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing